Ethicon Sarl v Gill [2021] FCAFC 29
The appeal was dismissed because the manufacturers' devices were found to be defective within the meaning of the Trade Practices Act 1974 (Cth) and the Australian Consumer Law, due to the significant, clinically significant risks posed, combined with inadequate warnings, misleading information, and marketing. The manufacturers breached their duty of care in failing to conduct adequate testing, post-market surveillance, and to provide necessary warnings. The information provided did not equip medical practitioners or consumers to make adequately informed decisions, and the knowledge of surgeons at the time did not include the relevant complications. The causation, limitation, and...
- Jurisdiction
- Australia
- Judgment Date
- 05 March 2021
- Procedural Posture
- Appeal / Full Court Appeal After Initial Trial With Orders
- Outcome
- Appeal dismissed, subject to variation to refine the form of one common-question order; original findings otherwise affirmed
- Legal Topics
- ['defective Goods' 'medical Devices Regulation' 'misleading or Deceptive Conduct' 'duty to Warn' 'injunctions' 'limitation of Actions' 'class Actions']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Appeal / Full Court Appeal After Initial Trial With Orders
Legal Issues
- 1 ['Whether the Ethicon medical devices were defective under the Trade Practices Act and Australian Consumer Law' 'Whether manufacturers failed to provide adequate warnings regarding risks' 'Whether there was misleading or deceptive conduct in marketing and instructions' 'Whether the manufacturers breached duty of care in negligence' 'Whether claims were statute-barred under limitation statutes' 'Appropriateness of grant of injunctive relief']
Ratio Decidendi
The appeal was dismissed because the manufacturers' devices were found to be defective within the meaning of the Trade Practices Act 1974 (Cth) and the Australian Consumer Law, due to the significant, clinically significant risks posed, combined with inadequate warnings, misleading information, and marketing. The manufacturers breached their duty of care in failing to conduct adequate testing, post-market surveillance, and to provide necessary warnings. The information provided did not equip medical practitioners or consumers to make adequately informed decisions, and the knowledge of surgeons at the time did not include the relevant complications. The causation, limitation, and...
Court Disposition
Appeal dismissed, subject to variation to refine the form of one common-question order; original findings otherwise affirmed
Orders
- ['Subject to order 2, the appeal be dismissed.' 'By 4pm on 19 March 2021 the parties provide: (a) any competing submissions as to the costs of the appeal; (b) an agreed or competing form of order addressing the issue referred to in [812] to [818] of the reasons of the Full Court (s 33ZB order); and (c) any...
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment